NUVL
USDNuvalent Inc. Class A Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$94.250
Kõrge
$95.225
Madal
$92.075
Maht
0.28M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
6.7B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.46M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Nuvalent to Present Patient-Reported Outcomes Data from ARROS-1 Trial of ROS1-Selective Inhibitor, Zidesamtinib, at 2025 IASLC ASCO North America Conference on Lung Cancer
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...
UBS Maintains Buy on Nuvalent, Raises Price Target to $132
UBS analyst David Dai maintains Nuvalent with a Buy and raises the price target from $114 to $132.
Nuvalent Highlights Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2025 Financial Results
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...
Piper Sandler Maintains Overweight on Nuvalent, Raises Price Target to $128
Piper Sandler analyst Kelsey Goodwin maintains Nuvalent with a Overweight and raises the price target from $112 to $128.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.